Wells Fargo & Company Issues Pessimistic Forecast for Keurig Dr Pepper (NASDAQ:KDP) Stock Price

Key Points

• Wells Fargo & Company has lowered the price target for Keurig Dr Pepper (NASDAQ:KDP) from $40.00 to $33.00, reflecting a cautious outlook despite maintaining an "overweight" rating.
• Several other analysts have also revised their ratings and price targets downward, including Citigroup decreasing theirs to $37.00 and BNP Paribas downgrading to "underperform."
• Keurig Dr Pepper's 52-week stock performance ranges from a high of $37.91 to a low of $25.92, with its recent opening price at $26.25.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) had its price target decreased by research analysts at Wells Fargo & Company from $40.00 to $33.00 in a research report issued on Thursday,Benzinga reports. The firm presently has an "overweight" rating on the stock. Wells Fargo & Company's target price indicates a potential upside of 25.71% from the stock's previous close.

Several other research analysts have also commented on the company. Citigroup lowered their price target on Keurig Dr Pepper from $41.00 to $37.00 and set a "buy" rating for the company in a research report on Tuesday, September 16th. BNP Paribas Exane lowered Keurig Dr Pepper from a "neutral" rating to an "underperform" rating in a research report on Monday. Hsbc Global Res lowered Keurig Dr Pepper from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, August 26th. HSBC restated a "hold" rating and set a $30.00 price target (down from $42.00) on shares of Keurig Dr Pepper in a research report on Tuesday, August 26th. Finally, BNP Paribas lowered Keurig Dr Pepper from a "neutral" rating to an "underperform" rating in a report on Monday. Ten investment analysts have rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $36.23.

Keurig Dr Pepper Price Performance

KDP stock opened at $26.25 on Thursday. Keurig Dr Pepper has a 52-week low of $25.92 and a 52-week high of $37.91. The business has a fifty day moving average of $31.27 and a two-hundred day moving average of $32.89. The stock has a market cap of $35.66 billion, a price-to-earnings ratio of 23.44, a price-to-earnings-growth ratio of 1.45 and a beta of 0.47. The company has a quick ratio of 0.40, a current ratio of 0.64 and a debt-to-equity ratio of 0.56.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last released its quarterly earnings results on Thursday, July 24th. The company reported $0.49 EPS for the quarter, hitting the consensus estimate of $0.49. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.The business had revenue of $4.16 billion during the quarter, compared to analyst estimates of $4.14 billion. During the same period last year, the business posted $0.45 earnings per share. The company's quarterly revenue was up 6.1% on a year-over-year basis. As a group, research analysts anticipate that Keurig Dr Pepper will post 1.92 earnings per share for the current year.

Insider Transactions at Keurig Dr Pepper

In related news, Director Robert James Gamgort sold 7,601 shares of the business's stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $35.91, for a total value of $272,951.91. Following the transaction, the director owned 2,284,568 shares in the company, valued at $82,038,836.88. The trade was a 0.33% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Mary Beth Denooyer sold 12,000 shares of the business's stock in a transaction dated Thursday, July 17th. The shares were sold at an average price of $33.66, for a total value of $403,920.00. Following the completion of the transaction, the insider owned 82,511 shares in the company, valued at $2,777,320.26. This trade represents a 12.70% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 447,601 shares of company stock worth $14,825,192 in the last quarter. Insiders own 0.40% of the company's stock.

Hedge Funds Weigh In On Keurig Dr Pepper

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Valeo Financial Advisors LLC acquired a new position in Keurig Dr Pepper during the 2nd quarter worth approximately $202,000. Osaic Holdings Inc. increased its position in Keurig Dr Pepper by 47.7% during the 2nd quarter. Osaic Holdings Inc. now owns 92,697 shares of the company's stock worth $3,068,000 after purchasing an additional 29,956 shares during the period. Orion Porfolio Solutions LLC increased its position in Keurig Dr Pepper by 7.4% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 134,979 shares of the company's stock worth $4,462,000 after purchasing an additional 9,248 shares during the period. Thrivent Financial for Lutherans increased its position in Keurig Dr Pepper by 1,329.6% during the 2nd quarter. Thrivent Financial for Lutherans now owns 1,193,247 shares of the company's stock worth $39,449,000 after purchasing an additional 1,109,780 shares during the period. Finally, Advisory Services Network LLC increased its position in Keurig Dr Pepper by 12.8% during the 2nd quarter. Advisory Services Network LLC now owns 76,229 shares of the company's stock worth $2,489,000 after purchasing an additional 8,638 shares during the period. Institutional investors and hedge funds own 93.99% of the company's stock.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.